"Dihydropyridines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pyridine moieties which are partially saturated by the addition of two hydrogen atoms in any position.
Descriptor ID |
D004095
|
MeSH Number(s) |
D03.383.725.203
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dihydropyridines".
Below are MeSH descriptors whose meaning is more specific than "Dihydropyridines".
This graph shows the total number of publications written about "Dihydropyridines" by people in this website by year, and whether "Dihydropyridines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 0 | 1 |
2004 | 1 | 0 | 1 |
2019 | 0 | 1 | 1 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dihydropyridines" by people in Profiles.
-
Martinez Manzano JM, Lo KB, Jarrett SA, Chiang B, Azmaiparashvili Z. Angioedema associated with the use of dihydropyridine calcium channel blockers-A case series. Ann Allergy Asthma Immunol. 2022 02; 128(2):228-229.
-
Starr MR, Dalvin LA, AbouChehade JE, Damento GM, Garcia MD, Shah SM, Hodge DO, Meissner I, Iezzi R, Bakri SJ. Classification of Strokes in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor. Ophthalmic Surg Lasers Imaging Retina. 2019 05 01; 50(5):e140-e157.
-
Liu HR, Gao F, Tao L, Yan WL, Gao E, Christopher TA, Lopez BL, Hu A, Ma XL. Antiapoptotic mechanisms of benidipine in the ischemic/reperfused heart. Br J Pharmacol. 2004 Jun; 142(4):627-34.
-
Yi GH, Burkhoff D, Zhang H, Zhu SM, Zwas D, Wang J. Hemodynamic effects of a calcium channel promoter, BAY y 5959, are preserved after chronic administration in ischemic heart failure in conscious dogs. J Pharmacol Exp Ther. 1998 Aug; 286(2):760-6.